Andreoli Sharon Phillips
Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, IN, USA.
Pediatr Nephrol. 2009 Feb;24(2):253-63. doi: 10.1007/s00467-008-1074-9. Epub 2008 Dec 13.
Acute kidney injury (AKI) (previously called acute renal failure) is characterized by a reversible increase in the blood concentration of creatinine and nitrogenous waste products and by the inability of the kidney to regulate fluid and electrolyte homeostasis appropriately. The incidence of AKI in children appears to be increasing, and the etiology of AKI over the past decades has shifted from primary renal disease to multifactorial causes, particularly in hospitalized children. Genetic factors may predispose some children to AKI. Renal injury can be divided into pre-renal failure, intrinsic renal disease including vascular insults, and obstructive uropathies. The pathophysiology of hypoxia/ischemia-induced AKI is not well understood, but significant progress in elucidating the cellular, biochemical and molecular events has been made over the past several years. The history, physical examination, and laboratory studies, including urinalysis and radiographic studies, can establish the likely cause(s) of AKI. Many interventions such as 'renal-dose dopamine' and diuretic therapy have been shown not to alter the course of AKI. The prognosis of AKI is highly dependent on the underlying etiology of the AKI. Children who have suffered AKI from any cause are at risk for late development of kidney disease several years after the initial insult. Therapeutic interventions in AKI have been largely disappointing, likely due to the complex nature of the pathophysiology of AKI, the fact that the serum creatinine concentration is an insensitive measure of kidney function, and because of co-morbid factors in treated patients. Improved understanding of the pathophysiology of AKI, early biomarkers of AKI, and better classification of AKI are needed for the development of successful therapeutic strategies for the treatment of AKI.
急性肾损伤(AKI)(以前称为急性肾衰竭)的特征是血肌酐和含氮废物浓度可逆性升高,以及肾脏无法适当调节液体和电解质平衡。儿童急性肾损伤的发病率似乎在上升,在过去几十年中,急性肾损伤的病因已从原发性肾脏疾病转变为多因素病因,尤其是在住院儿童中。遗传因素可能使一些儿童易患急性肾损伤。肾损伤可分为肾前性肾衰竭、包括血管损伤在内的内在性肾脏疾病以及梗阻性尿路病。缺氧/缺血性急性肾损伤的病理生理学尚未完全了解,但在过去几年中,在阐明细胞、生化和分子事件方面已取得重大进展。病史、体格检查以及实验室检查,包括尿液分析和影像学检查,可以确定急性肾损伤的可能病因。许多干预措施,如“肾剂量多巴胺”和利尿治疗,已被证明不会改变急性肾损伤的病程。急性肾损伤的预后高度依赖于急性肾损伤的潜在病因。任何原因导致急性肾损伤的儿童在初次损伤后数年都有患晚期肾病的风险。急性肾损伤的治疗干预大多令人失望,这可能是由于急性肾损伤病理生理学的复杂性、血清肌酐浓度是肾功能的不敏感指标这一事实,以及治疗患者存在合并症因素。为了制定成功治疗急性肾损伤的策略,需要更好地了解急性肾损伤的病理生理学、急性肾损伤的早期生物标志物以及对急性肾损伤进行更好的分类。